Cabinet’s “safe supply” drug policy has had minimal impacts despite costing more than $820 million, says a health department report. Researchers said while supervised consumption sites saved some lives “opioid-related deaths have remained higher than pre-pandemic levels.”
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
